Radiation Therapy News

1 Million Patients Treated with Leksell Gamma Knife Surgery — a Milestone for Elekta

World neurosurgery leaders gathered in Amsterdam May 15-19 for the 18th International Leksell Gamma Knife Society Meeting. The annual conference is dedicated to Gamma Knife surgery in the treatment of intracranial disorders, and covers topics such as radiosurgery, benign tumors, vascular disorders, malignant tumors, ophthalmological disorders, functional disorders, radiobiology, physics, quality assurance, and imaging. At the meeting, Elekta Instrument AB… [ 1052 more words. ]

http://radiationtherapynews.com/2016/05/20/elekta-surpasses-one-million-patients-treated-leksell-gamma-knife/

1 Million Patients Treated with Leksell Gamma Knife Surgery — a Milestone for Elekta World neurosurgery leaders gathered in Amsterdam May 15-19 for the 18th International Leksell Gamma Knife Society Meeting. The annual conference is dedicated to Gamma Knife surgery in the treatment of intracranial disorders, and covers topics such as radiosurgery, benign tumors, vascular disorders,…

MD Anderson Cancer Center to Acquire Latest in Elekta Radiotherapy Systems

The University of Texas MD Anderson Cancer Center has signed a contract with Elekta to acquire Elekta Infinity linear accelerators and brachytherapy afterloaders, as well as software and services. Elekta, which specializes in tools and systems to treat cancer and brain disorders, claims that its innovations are behind most of the critical technological advances in radiation oncology over the last 30 years. [ 285 more words. ]

http://radiationtherapynews.com/2016/05/04/md-anderson-cancer-center-to-acquire-elekta-linear-accelerators-and-other-radiotherapy-solutions/

MD Anderson Cancer Center to Acquire Latest in Elekta Radiotherapy Systems Read about MD Anderson Cancer Center plans to acquire the latest Elekta radiotherapy systems, including linear accelerators and brachytherapy afterloaders.

Partial Breast Radiation as Effective as Entire Breast Radiotherapy in Low-Risk Cancers, UK Study Reports

Radiotherapy after breast cancer surgery that's limited to former tumor sites is just as effective in treating early cancers as whole breast radiation and has fewer long-term side effects, according to results of a clinical study presented at the recent 10th European Breast Cancer Conference. The trial, called IMPORT LOW and supported by Cancer Research UK, looked at ways to improve radiotherapy treatment for low-risk early stage… [ 359 more words. ]

http://radiationtherapynews.com/2016/04/26/partial-breast-radiotherapy-cuts-breast-cancer-side-effects/

Partial Breast Radiation as Effective as Entire Breast Radiotherapy in Low-Risk Cancers, UK Study Reports Read about the IMPORT LOW study, finding that targeted and partial breast radiotherapy is as effective as full breast radiation in early, low-risk cancers.

Side Effects of Radiation Therapy May Be Eased by a Diet Rich in Tomatoes, Study Reports

Researchers in the U.K. and Germany report that lycopene, a carotenoid pigment present in tomatoes, can protect human lymphoid cells against the harmful effects of gamma radiation during radiation therapy, a common treatment for cancer, and could be used as a dietary intervention. The study, “A dramatic effect of oxygen on protection of human cells against γ-radiation by lycopene… [ 333 more words. ]

http://radiationtherapynews.com/2016/04/08/radiation-therapy-side-effects-may-be-attenuated-by-tomato-carotenoids/

Side Effects of Radiation Therapy May Be Eased by a Diet Rich in Tomatoes, Study Reports Read research finding that lycopene, a carotenoid pigment in tomatoes, can protect against the harmful effects of gamma radiation during radiation therapy.

Novel Radiation Therapy Software for Detecting Breast Cancer on Display at European Congress of Radiology

iCAD Inc. recently announced its latest innovative imaging tool for early detection of breast cancer based on tomosynthesis computer-aided detection (CAD). The technology is on display at the European Congress of Radiology (ECR) in Vienna, Austria, through March 6. According to a study published in the journal Cancers, breast cancer is the most common invasive type of cancer in women, affecting 12 percent of women worldwide. [ 371 more words. ]

http://radiationtherapynews.com/2016/03/22/icad-announces-breakthrough-technology-for-use-with-digital-breast-tomosynthesis-exams-at-the-european-congress-of-radiology/

Novel Radiation Therapy Software for Detecting Breast Cancer on Display at European Congress of Radiology iCAD Inc. recently announced its latest innovative imaging tool for early detection of breast cancer based on tomosynthesis computer-aided detection (CAD). The technology is on display at the European Congress of Radiology (ECR) in Vienna, Austria, through March 6. According to a study published in…

Lung Cancer in Smokers More Accurately Detected Using CT Scans than X-rays, Center Reports

A comprehensive lung cancer screening program that uses CT scan technology developed at Intermountain Medical Center in Salt Lake City may provide smokers with a more precise way of determining if they have lung cancer. The screening program drew on the results of the National Lung Screening Trial, a comprehensive trial in which CT scans were compared with typical chest X-rays for their accuracy in detecting lung cancer. [ 375 more words. ]

http://radiationtherapynews.com/2016/02/24/lung-cancer-smokers-accurately-detected-using-ct-scans-x-rays-center-reports/

Lung Cancer in Smokers More Accurately Detected Using CT Scans than X-rays, Center Reports Read about a lung screening program at Intermountain Medical Center in Salt Lake City that uses CT scans to more accurately detect lung cancer in smokers.

Xoft Single-Dose Radiation Therapy for Early-Stage Breast Cancer Shows Continuing Promise

iCAD Inc., a company that delivers innovative cancer detection and radiation therapy solutions, recently presented updated clinical data on the use of intraoperative radiation therapy (IORT) with the Company’s Xoft Axxent Electronic Brachytherapy System to treat patients with early-stage breast cancer at the San Antonio Breast Cancer Symposium held in December in San Antonio, Texas. Management of Nashua, New Hampshire-based iCAD said that so far, more than 2,000 patients with early-stage breast cancer have received treatment with IORT using the… [ 253 more words. ]

http://radiationtherapynews.com/2016/02/11/xoft-single-dose-radiation-therapy-early-stage-breast-cancer-shows-continuing-promise/

Xoft Single-Dose Radiation Therapy for Early-Stage Breast Cancer Shows Continuing Promise Intraoperative Radiation Therapy For Breast Cancer Shows Continuing Efficacy in Trial

Langerhans Cells Protect Skin Tumors from Radiation Treatment

Researchers at the Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, have discovered how tumors can survive the effects of radiotherapy. While studying skin tumors, the team discovered that during radiotherapy, skin immune cells — called Langerhans cells — are activated to repair the DNA damage caused by the radiation. When Langerhans cells were exposed to radiation, they could repair their own DNA. [ 287 more words. ]

http://radiationtherapynews.com/2016/01/25/langerhans-cells-protect-skin-tumors-from-radiation-treatment/

Langerhans Cells Protect Skin Tumors from Radiation Treatment Read about a new study discovering how skin Langerhans cells protect skin tumors from the effects of radiotherapy

Lung Cancer Patients Treated with IMRT Have Less Lung Toxicity and Better Tolerance to Chemotherapy

The analysis of an international clinical trial including patients suffering from locally advanced non-small cell lung cancer (NSCLC) showed that those treated with intensity modulated radiation therapy (IMRT) had a significant decrease in lung toxicity and improved chemotherapy tolerance when compared to patients treated with 3-dimensional conformal radiation therapy (3-D CRT). The results were presented by Stephen Chun, M.D., fellow, Radiation Oncology at… [ 406 more words. ]

http://radiationtherapynews.com/2015/12/15/lung-cancer-patients-treated-imrt-less-lung-toxicity-better-tolerance-chemotherapy/

Lung Cancer Patients Treated with IMRT Have Less Lung Toxicity and Better Tolerance to Chemotherapy The analysis of an international clinical trial including patients suffering from locally advanced non-small cell lung cancer (NSCLC) showed that those treated with intensity modulated radiation therapy (IMRT) had a significant decrease in lung toxicity and improved chemotherapy tolerance when compa…

New Boron Formulation May Improve Treatment of Brain Tumors

Brain tumors are very difficult to treat without causing serious damage to this complex organ, prompting scientists to search for therapies that selectively target and kill malignant brain cells. A research team at Okayama University and Kinki University developed a boron-based compound (BSH) that accumulates in malignant cells rather than in healthy cells, which can be used in radiation therapy. The study entitled “ [ 293 more words. ]

http://radiationtherapynews.com/2015/11/24/a-new-boran-formulation-may-improve-treatment-of-brain-tumors/

New Boron Formulation May Improve Treatment of Brain Tumors Read more on radiation therapy with boron to treat brain tumors

Instapeer Mobile App – No One Should Face Cancer Alone

No one should face alone. Instapeer is an app that helps people connect with cancer patients, survivors, and caregivers.

Instapeer Mobile App – No One Should Face Cancer Alone No one should go through cancer alone

ASCO Revises ASTRO Guidelines For Treatment Of Women With Endometrial Cancer

The number of women of child-bearing age, diagnosed with endometrial cancer, has been on the rise in the United States in recent times. Some of the main factors behind this phenomenon include obesity, diabetes and delay in child-bearing. This has been a matter of concern and the topic of intense discussion. The main motto of these discussions has been protection of ovarian function and fertility and prevention of sterility. [ 326 more words. ]

http://radiationtherapynews.com/2015/09/08/asco-revises-astro-guidelines-for-treatment-of-women-with-endometrial-cancer/

ASCO Revises ASTRO Guidelines For Treatment Of Women With Endometrial Cancer Read about ASCO's modulation of ASTRO guidelines which provide standard treatment solutions for women with endometrial cancer.

Some Hodgkin Lymphoma Patients Do Not Need Radiotherapy

Recent results from clinical trials have shown that some Hodgkin lymphoma patients could avoid going through damaging sessions of radiotherapy and still remain free from the disease 3 years later. Such findings evidence that many patients suffering with early stage Hodgkin lymphoma could see their diseases cured with chemotherapy alone, without the need for radiotherapy and the exposure to its long-term side effects such as second cancers and heart disease. [ 366 more words. ]

http://radiationtherapynews.com/2015/09/01/hodgkin-lymphoma-patients-not-need-radiotherapy/

Some Hodgkin Lymphoma Patients Do Not Need Radiotherapy Read How Some Hodgkin Lymphoma Patients Do Not Need Radiotherapy.

September is the Blood Cancer Awareness Month and you have to play a role in this story! Share the word and read all you need to know about and here: http://lymphomanewstoday.com/

Esteya: An Alternative Therapeutic Option For High Dose Radiation Of Skin Cancer

Esteya electronic brachytherapy is a new method to treat skin cancer in a more specific way, targeting only the cancerous site without harming the surrounding healthy organs. This high precision treatment solution, which has been developed by Elekta AB., has the capacity to mimic high dose radiation (HDR) brachytherapy by bringing a miniaturized x-ray source very close to the affected site and preventing healthy skin cells from radiation damage. [ 206 more words. ]

http://radiationtherapynews.com/2015/08/04/esteya-alternative-therapeutic-option-high-dose-radiation-skin-cancer/

Esteya: An Alternative Therapeutic Option For High Dose Radiation Of Skin Cancer Read about an effective alternative to skin cancer treatment, which causes less damage to healthy skin cells as compared to conventional radiation therapies.

Risk of RT-BOOP for Young Breast Cancer Patients is Low

Although radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) is a possible side effect of radiation therapy in women with breast cancer, a study from the Department of Radiation Oncology at the University of Tsukuba in Japan found that the risk is quite low but is more prevalent in older women. "Radiation-induced Bronchiolitis Obliterans Organizing Pneumonia (BOOP) Syndrome in Breast Cancer Patients is Associated With Age… [ 306 more words. ]

http://radiationtherapynews.com/2015/07/31/risk-of-rt-boop-for-young-breast-cancer-patients-is-low/

Risk of RT-BOOP for Young Breast Cancer Patients is Low Read about how the risk of RT-BOOP is low for young breast cancer patients.

FDA Approves Neupogen As The First Drug for Radiation Therapy-Related Injuries

Researchers at the University of Maryland School of Medicine (UM SOM) provided important data on a non-human clinical model of high-dose radiation that ultimately led the U.S. Food and Drug Administration (FDA) to recently approve the use of the drug Neupogen for the treatment of harmful effects of radiation exposure. This is the first drug to be ever approved as a therapeutic agent for acute radiation injury. [ 449 more words. ]

http://radiationtherapynews.com/2015/06/24/fda-approves-neupogen-first-drug-radiation-therapy-related-injuries/

FDA Approves Neupogen As The First Drug for Radiation Therapy-Related Injuries Read about the FDA approval of Neupogen as the first drug for radiation therapy-related injuries.

Targeted, High-Dose Stereotactic Body Radiation Therapy Appears to Benefit Some Patients with Pancreatic Cancer

This year, oncology researchers from John Hopkins Kimmel Cancer Center have released results from two preliminary studies showing that stereotactic body radiotherapy (SBRT) may be an advantageous choice in comparison to traditional radiation therapy options due to the timeliness and accuracy of the therapy. The study findings also suggest that SSBRT is as safe treatment option for certain patients whose pancreatic cancer tumors have advance but not metastasized. [ 448 more words. ]

http://radiationtherapynews.com/2015/06/24/targeted-high-dose-stereotactic-body-radiation-therapy-appears-benefit-patients-pancreatic-cancer/

Targeted, High-Dose Stereotactic Body Radiation Therapy Appears to Benefit Some Patients with Pancreatic Cancer Chemoradiation, advanced pancreatic cancer, stereotactic body radiotherapy, The Kimmel Cancer Center, John Hopkins University

PET/CT Highly Sensitive For Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma (NHL) can range from easy to treat to very hard to treat as a consequence of very aggressive forms of the disease. For harder cases, post-treatment surveillance through molecular imaging could represent a new and life-saving approach to treatment. These are the latest conclusions of Johns Hopkins Medical Institutions' researchers, presented during the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging… [ 286 more words. ]

http://radiationtherapynews.com/2015/06/17/petct-highly-sensitive-non-hodgkin-lymphoma/

PET/CT Highly Sensitive For Non-Hodgkin Lymphoma Read More About PET/CT Over 95 Percent Sensitive For Non-Hodgkin Lymphoma.

Focused Ultrasound: A Novel Promise In Cancer Immunotherapy

Cancer immunotherapy has been a selective and safe option for treatment of certain types of cancer when compared with radiation and chemotherapy, as immunotherapy targets specific immune cells of the body to combat tumors, thus acting in a more specific and targeted manner. Due to the immune system’s capacity to selectively target and destroy cancer antigens, cancer immunotherapy could provide durable and healthier therapeutic options to patients. [ 186 more words. ]

http://radiationtherapynews.com/2015/06/19/focused-ultrasound-novel-promise-cancer-immunotherapy/

Focused Ultrasound: A Novel Promise In Cancer Immunotherapy Read about how Focused Ultrasound is coming off as a handy choice in eliciting an immune response in cancer bearing hosts, with scopes of reducing harmful effects of radiation and chemotherapy.

Total Marrow Irradiation: The Latest Gift Of Technology To Radiation Therapy

The first Total Marrow Irradiation (TMI) was successfully performed 10 years ago at the City of Hope in Duarte, California, using the TomoTherapy System. Since then, this technique has found applications in a number of medical centers worldwide, despite limitations associated with conventional radiation therapies. Total body radiation (the conventional approach) is a necessity in cases of bone marrow transplants (BMT). [ 465 more words. ]

http://radiationtherapynews.com/2015/06/15/total-marrow-irradiation-latest-gift-technology-radiation-therapy/

Total Marrow Irradiation: The Latest Gift Of Technology To Radiation Therapy Read about Total Marrow Irradiation, which has the ability to work as good as radiation therapy, but without causing equal damage to healthy organs.

Phase III Study Validates Acupuncture-Like Electrical Nerve Stimulation for Radiation-Induced Dry Mouth

Results from a Phase III trial conducted by the Radiation Therapy Oncology Group (RTOG 0537), recently published in the International Journal of Radiation Oncology, show that acupuncture-like, transcutaneous electrical nerve stimulation (ALTENS) is as effective as pilocarpine for radiation-induced xerostomia (dry mouth) treatment. RTOG 0537 is a multi-center, randomized phase II/III trial which assessed the efficacy of ALTENS in comparison to pilocarpine. [ 422 more words. ]

http://radiationtherapynews.com/2015/06/08/phase-iii-study-validates-acupuncture-like-electrical-nerve-stimulation-radiation-induced-dry-mouth/

Phase III Study Validates Acupuncture-Like Electrical Nerve Stimulation for Radiation-Induced Dry Mouth Read more about Results of RTOG 0537 Phase III study indicating Acupuncture-Like Electrical Nerve Stimulation for Radiation-Induced Dry Mouth

Whole Brain Radiation Therapy Poses Threat to Cognitive Function

Patients undergoing whole brain radiation therapy (WBRT) are at a significant risk for declined cognitive function relative to patients receiving radiosurgery. A team of researchers at The University of Texas MD Anderson Cancer Center, led by Paul Brown, MD, is working to understand whether or not WBRT should continue to be used to treat cancer patients with brain metastases. According to their most recent work presented at the… [ 430 more words. ]

http://radiationtherapynews.com/2015/06/05/whole-brain-radiation-therapy-poses-threat-cognitive-function/

Whole Brain Radiation Therapy Poses Threat to Cognitive Function Read about how whole brain radiation therapy poses a threat to cognitive function.

Oncology Institute In Moscow Opens PET Diagnostics And High-Accuracy Radiotherapy Departments

The Group of Companies European Medical Center (GEMC) is now the first private clinic in Russia to open a Positron Emission Tomography (PET-CT) Department with its own pharmaceutical production and a Radiation Cancer Therapy Department including two linear accelerators. GEMC created an Institute of Oncology in Russian private clinics implementing an oncologic comprehensive protocol with high-accuracy diagnostics and screening (MRI, PET/CT, pathomorphology, immunohistochemistry, genetic testing), radiotherapy, chemotherapy, da Vinci robot-assisted surgery, psychological assistance for patients and families, pain treatment and palliative care. [ 276 more words. ]

http://radiationtherapynews.com/2015/06/03/oncology-institute-moscow-opens-pet-diagnostics-high-accuracy-radiotherapy-departments/

Oncology Institute In Moscow Opens PET Diagnostics And High-Accuracy Radiotherapy Departments Read More About Oncology Institute In Moscow Opens PET Diagnostics And High-Accuracy Radiotherapy Departments

PROCLAIM Results To Be Presented At ASCO 2015 Meeting

Eli Lilly and Company recently announced that the results of the PROCLAIM Phase III trial will be presented during the Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago, May 29th -June 2nd. PROCLAIM was a Phase III randomized, superiority trial that evaluated the efficacy of Lilly's ALIMTA (pemetrexed for injection), in combination with cisplatin with concurrent radiation followed by maintenance ALIMTA in patients with locally-advanced nonsquamous… [ 283 more words. ]

http://radiationtherapynews.com/2015/05/31/proclaim-results-presented-asco-2015-meeting/

PROCLAIM Results To Be Presented At ASCO 2015 Meeting Read more about PROCLAIM Results that will be Presented at the ASCO 2015 Meeting

Clinical Trial Finds Stereotactic Ablative Radiotherapy Offers Better Overall Survival to Early...

Clinical Trial Finds Stereotactic Ablative Radiotherapy Offers Better Overall Survival to Early Lung Cancer Patients http://wp.me/p4NNB7-S7

Clinical Trial Finds Stereotactic Ablative Radiotherapy Offers Better Overall Survival to Early... A new study led by researchers at The University of Texas MD Anderson Cancer Center and the VU University Medical Center in The Netherlands revealed that stereotactic ablative radiotherapy (SABR) offers a better survival rate than surgery in patients with non-small cell lung cancer (NSCLC). The study was recently published in the journal The Lancet Oncology and is entitled “ [ 551 more words. ]

Additional Rounds of Stereotactic Radiosurgery Do Not Influence Survival in Patients with Brain...

Additional Rounds of Stereotactic Radiosurgery Do Not Influence Survival in Patients with Brain Metastases http://wp.me/p4NNB7-RC

Additional Rounds of Stereotactic Radiosurgery Do Not Influence Survival in Patients with Brain... Dr. Deborah C. Marshall recently presented her research findings on radiosurgery during the 83rd American Association of Neurological Surgeons (AANS) Annual Scientific Meeting held from May 2 to 6, 2015 in Washington, D.C. According to an AANS press release, the presentation was entitled “Survival Patterns of Patients with Cerebral Metastases after Multiple Rounds of Stereotactic Radiosurgery (SRS).” Dr. [ 319 more words. ]

ASTRO Releases New Guideline on Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

ASTRO Releases New Guideline on Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer http://wp.me/p4NNB7-RA

ASTRO Releases New Guideline on Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer The American Society for Radiation Oncology (ASTRO) recently announced a new guideline for the use of radiotherapy in the most common type of lung cancer — non-small cell lung cancer (NSCLC). The guideline is entitled “Definitive and adjuvant radiotherapy in locally advanced non-small cell lung cancer: An American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline” and its executive summary was recently published in the journal… [ 427 more words. ]

Ae**us Announces Results From Study On Experimental Therapy Doubling Survival Rates After...

Ae**us Announces Results From Study On Experimental Therapy Doubling Survival Rates After Radiation-Induced Lung Damage http://wp.me/p4NNB7-Rv

Ae**us Announces Results From Study On Experimental Therapy Doubling Survival Rates After... Ae**us Pharmaceuticals, Inc., a biotechnology company advancing compounds to address protection against chemical and radiological threats, recently announced the results of a successful study in non-human primates (NHPs) demonstrating that a 60-day treatment with AEOL 10150 doubled survival (from 25 percent to 50 percent) in animals that received radiation exposure to the lungs. The study's outcomes were reported originally by the firm in September 2014 and the full results include radiographic and clinical measures of secondary parameters of lung injury and imaging of potential bio-markers for lung injury. [ 327 more words. ]

Study Explores Use of Combined Brachytherapy for Treatment of Cervical Cancer

Study Explores Use of Combined Brachytherapy for Treatment of Cervical Cancer http://wp.me/p4NNB7-Rh

Study Explores Use of Combined Brachytherapy for Treatment of Cervical Cancer Results from the first large international study to explore late effects of a combined brachytherapy form to treat cervical cancer have shown that the procedure is effective in delivering higher doses of radiation to the tumor without causing late adverse events. Brachytherapy is a form of radiotherapy that involves placing a radioactive source near to, or precisely within the tumor. It is usually performed following an MRI or CT scan and targets the exact position of the cancer, also termed image-guided brachytherapy (IGBT). [ 593 more words. ]

PlasmaTech Develops New Therapeutic Approach for Radiation Therapy-Related Side Effects in...

PlasmaTech Develops New Therapeutic Approach for Radiation Therapy-Related Side Effects in Cancer Patients http://wp.me/p4NNB7-R2

PlasmaTech Develops New Therapeutic Approach for Radiation Therapy-Related Side Effects in... More than 250,000 new cases of colon, re**al, bladder, cervical, prostate, testicular and endometrial cancer are estimated by the National Cancer Institute at the National Institutes of Health to be diagnosed every year in the United States. Around 50% of these patients are thought to eventually require radiation therapy in the affected pelvic region, and of these, around 75% will experience radiation proctitis or re**al mucositis. [ 320 more words. ]

Brachytherapy Improves Survival For Inoperable Early Stage Endometrial Cancer

Study Shows Brachytherapy Improves Survival For Inoperable Early Stage Endometrial Cancer http://wp.me/p4NNB7-Qx

Brachytherapy Improves Survival For Inoperable Early Stage Endometrial Cancer According to a recent study presented during the 3rd ESTRO Forum in Barcelona, Spain, women with early stage endometrial cancer who are inoperable tend to live longer when treated with brachytherapy with or without external beam radiation. Brachytherapy is a type of internal radiotherapy in which a radioactive source is placed in or close to the tumor. It has been used to treat inoperable endometrial cancer, but there is no randomized evidence that scientifically supports this approach. [ 546 more words. ]

National Cancer Institute grants $2.88 Million for Research and Development of Breast CT Scanning

National Cancer Institute grants $2.88 Million for Research and Development of Breast CT Scanning http://wp.me/p4NNB7-R0

National Cancer Institute grants $2.88 Million for Research and Development of Breast CT Scanning The National Cancer Institute granted John M. Boone, a UC Davis professor of radiology and medical physicist, with an award of $2.88 million to advance and study computed tomography (CT) as a detection technique for breast cancer. Dr. Boone is a pioneer researcher in computed tomography for the breast. For more than 15 years, he and a team of physicians and researchers have been working on developing the technology and have successfully developed four computed tomography breast CT scanners, each of them with consecutive improvements in spatial resolution. [ 368 more words. ]

High Radiotherapy Dose Improves Survival in Children With Specific Brain Cancer

High Radiotherapy Dose Improves Survival in Children With Specific Brain Cancer http://wp.me/p4NNB7-Qv

High Radiotherapy Dose Improves Survival in Children With Specific Brain Cancer Two new studies recently presented at the 3rd ESTRO Forum in Barcelona in Spain revealed that an increase in radiotherapy dose received by children with intracranial ependymoma can significantly improve survival rate. An ependymoma is a tumor in the ependymal cells lining the hollow cavities of the brain. Although rare in adults, ependymomas are the third most common brain tumor in children. [ 518 more words. ]

Permanent Radiotherapy Implants Reported to Decrease Prostate Cancer Recurrence Risk at 5 Years

Permanent Radiotherapy Implants Reported to Decrease Prostate Cancer Recurrence Risk at 5 Years http://wp.me/p4NNB7-Qs

Permanent Radiotherapy Implants Reported to Decrease Prostate Cancer Recurrence Risk at 5 Years Dr. James Morris from the British Columbia Cancer Agency (BCCA) in Canada recently presented at the 3rd ESTRO Forum in Barcelona, Spain the results of the ASCENDE-RT trial (Androgen Suppression Combined with Elective Nodal and Dose Escanodal and Dose Escalated Radiation Therapy) assessing prostate cancer treatment via low-dose-rate prostate brachytherapy (LDR-PB), characterized by the use of permanent radioactive implants, in comparison to other radiation therapy delivery methods. [ 564 more words. ]